New Key Statistics Module, Z-Score and F-Score
SZSE:300630 Key Ratios
Market Cap ¥ M | 3,709.07 |
Enterprise Value ¥ M | 5,932.92 |
P/E(ttm) | 42.54 |
PE Ratio without NRI | 25.98 |
Forward PE Ratio | -- |
Price/Book | 1.25 |
Price/Sales | 2.80 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.25 |
Revenue (TTM) ¥ M | 1,396.00 |
EPS (TTM) ¥ | 0.19 |
Beneish M-Score | -2.02 |
10-y EBITDA Growth Rate % | 25.10 |
5-y EBITDA Growth Rate % | 3.40 |
y-y EBITDA Growth Rate % | -6.30 |
EV-to-EBIT | 30.73 |
EV-to-EBITDA | 30.73 |
PEG | 7.64 |
Shares Outstanding M | 451.78 |
Net Margin (%) | 6.18 |
Operating Margin % | 15.29 |
Pre-tax Margin (%) | 9.03 |
Quick Ratio | 1.08 |
Current Ratio | 1.29 |
ROA % (ttm) | 1.37 |
ROE % (ttm) | 3.15 |
ROIC % (ttm) | 2.80 |
Dividend Yield % | 0.93 |
Altman Z-Score | 1.27 |
SZSE:300630 Number of Guru Trades
SZSE:300630 Volume of Guru Trades
Gurus Latest Trades with SZSE:300630
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300630 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hainan Poly Pharm Co Ltd Insider Transactions
No Available Data